Navigation Intervention for Adolescent and Young Adult Cancer Survivors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award. The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Zdiagnozowano u Ciebie raka piersi, jajnika, szyjki macicy, jądra, jelita grubego/odbytnicy, czerniaka, macicy, mięsaka lub tarczycy w wieku 15-39 lat.
- •Masz teraz od 21 do 45 lat.
- •Leczenie raka odbyło się w ośrodku Kaiser Permanente Southern California.
- •Posiadasz aktualne ubezpieczenie Kaiser Permanente.
✗ Disqualifies
- •Nie możesz mieć w przeszłości ani obecnie białaczki lub chłoniaka.
- •Nie możesz mieć rozsianego raka (przerzutów) w momencie diagnozy.
Simplified criteria — AI translation
Trial details
- Minimum age
- 21 Years
- Maximum age
- 45 Years
- Last updated (source)
- July 6, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
KP Southern California - Department of Research & Evaluation
Pasadena, United States
Trial contact
Erin E Hahn, PhD
Corrine E. Munoz-Plaza, MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.